Primary Hyperparathyroidism of Postmenopausal Women

References

• Adami S., Mian M., Bertoldo F., Rossini M., Jayawerra P., O'Riordan J. L.H., Lo Cascio V. Regulation of calcium - parathyroid hormone feed-back in primary hyperparathyroidism: Effects of bisphophonate treatment. Clin Endocrinol 1990; 33: 391
   PubMed Web of Science ®Google Scholar
• Adami S., Braga V., Squaranti R., Rossini M., Gatti D., Zamberlan N. Bone measurements in asymptomatic primary hyperparathyroidism. Bone 1998; 22: 565
   PubMed Web of Science ®Google Scholar
• Akmal M., Kasim S. E., Soliman A. R., Massry S. G. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 1990; 37: 854
   PubMed Web of Science ®Google Scholar
• Albright F., Aub J. C., Bauer W. Hyperparathyroidism: A common and polymorphic condition as illustrated by seventeen cases from one clinic. JAMA 1934; 102: 1276
   Google Scholar
• Albright F., Reifenstein E. C. The parathyroid glands and metabolic bone disease. Williams and Wilkins, USA 1948
   Google Scholar
• Alcarón R. D., Franceschini J. A. Hyperparathyroidism and paranoid psychosis, case report and review of the literature. Brit J Psychiatry 1984; 145: 477
   PubMed Web of Science ®Google Scholar
• Andersen T., McNair P., Hyldstrup L., Fogh-Andersen N., Nielsen T. T., Astrup A., Transbol I. Secondary hyperparathyroidism of morbid obesity regresses during weight reduction. Metabolism 1988; 37: 425
   PubMed Web of Science ®Google Scholar
• Attie J. N., Khafif R. A. Surgical explorations in in asymptomatic hypercalcemia: Early treatment of hyperparathyroidism. Am J Surg 1976; 132: 449
   PubMed Web of Science ®Google Scholar
• Bannon M. P., van Heerden J. A., Palumbo P. J., Ilstrup D. M. The relationship between primary hyperparathyroidism and diabetes mellitus. Ann Surg 1988; 207: 430
   PubMed Web of Science ®Google Scholar
• Bauer W., Aub J. C., Albright F. Studies of calcium phosphorous metabolism: study of bone trabeculae as ready avaible reserve supply of calcium. J Exp Med 1929; 49: 145
   PubMedGoogle Scholar
• Benson L., Ljunghall S., Groth T., Falk H., Hvarfner A., Rastad J., Wide L., Åkerström G. Optimal discrimination of mild hyperparathyroidsm with serum calcium, ionized calcium and parathyroid hormone measurements. Ups J Med Sci. 1987; 92: 147
   PubMed Web of Science ®Google Scholar
• Bergenfelz A., Valdermarsson S., Tibblin S. Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: Evidence of detrimental effects of severe parathyroid disease. Surgery 1996; 119: 624
   PubMed Web of Science ®Google Scholar
• Bilezikian J. P., Silverberg S. J., Gartenberg F., Kim T.-S., Jacobs T. P., Siris E. S., Shane E. Clinical presentation of primary hyperparathyroidism. The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 457, Ch 26
   Google Scholar
• Bjerneroth G., Juhlin C., Grimelius L., Rastad J., Åkerström G. Improvement in histological diagnosis of primary hyperparathyroidism with a monoclonal antiparathyroid antibody. Endocrine Pathol 1992; 3: 83
   PubMed Web of Science ®Google Scholar
• Block M. A., Dailey G. E., III, Muchmore D. E. Bone demineralization, a factor of increasing significance in the management of primary hyperparathyroidism. Surgery 1989; 106: 1063
   PubMed Web of Science ®Google Scholar
• Boivin P., Bernard J. F. Polycythaemia and hyperparathyroidism: A fortuitous association?. Eur J Heamatol 1992; 49: 153
   PubMed Web of Science ®Google Scholar
• Bonjer J. H., Bruining H. A., Birkenhager J. C., Nishiyama R. H., Jones M. A., Bagwell C. B. Single and multigland disease in primary hyprerparathyroidism: Clinical follow-up, histopathology and flow cytometric DNA analysis. World J Surg 1992; 16: 732
   PubMed Web of Science ®Google Scholar
• Boonstra C. E., Jackson C. E. Serum calcium survey for hyperparathyroidism; results in 50,000 clinic patients. Ann J Clin Pathol 1970; 55: 523
   Web of Science ®Google Scholar
• Boucher A., D'Amour P., Hamel L., Fugere P., Gascon-Barre M., Lepage R., Ste-Marie L. G. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women. J Clin Endocrinol Metab 1989; 68: 831
   PubMed Web of Science ®Google Scholar
• Boxer M., Ellman L., Geller R., Wang C-A. Anemia in primary hyperparathyroidism. Arch Int Med 1977; 137: 588
   PubMedGoogle Scholar
• Broadus A. E., Magee J. S., Malette L. E., Horst R. L., Lang R., Baron R. A detailed evaluation of oral phosphorous therapy in selected patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1983; 56: 953
   PubMed Web of Science ®Google Scholar
• Brothers T. E., Thompson N. W. Surgical treatment of primary hyperparathyroidism in elderly patients. Acta Chir Scand 1987; 153: 175
   PubMedGoogle Scholar
• Brown E. M., Leombruno R., Thatcher J., Burrowes M. The acute secretory response to alterations in extracellular calcium concentration and dopamin in perifused bovine parathyroid cells. Endocrinology 1985; 116: 1123
   PubMed Web of Science ®Google Scholar
• Brown E., Enyedi P., LeBoff M., Rotberg J., Preston J., Chen C. High extracellular Ca2+ and Mg2+ stimulate accumulation of inositol phosphates in bovine parathyroid cells. FEBS Lett 1987; 218: 113
   PubMed Web of Science ®Google Scholar
• Brown G. G., Preisman R. C., Kleerekoper M. Neurobehavioral symptoms in mild hyperparathyroidism: Related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 1987; 35: 211
   PubMedGoogle Scholar
• Bruining H. A., van Houten H., Juttman J. R., Lamberts S. W.J., Birkenhäger J. C. Results of opertaive treatment of 615 patients with primary hyperparathyroidism. World J Surg 1981; 5: 85
   PubMedGoogle Scholar
• Burney R. E., Jones K. R., Wilson J. Coon, Blewitt D. K., Herm A. M. Assessments of patient outcomes after operation for primary hyperparathyroidism. Surgery 1996; 120: 1013
   PubMed Web of Science ®Google Scholar
• Burney R. E., Jones K. R., Peterson M., Christy B., Thompson N. W. Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 1998; 124: 987
   PubMed Web of Science ®Google Scholar
• Canalis E., Hock J. M., Raisz L. G. Anabolic and catabolic effects of parathyroid hormones on bone and interactions with growth factors. The Parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 65, Ch 4
   Google Scholar
• Carling T., Rastad J., Kindmark A., Lundgren E., Ljunghall S., Åkerström G. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery 1997; 122: 1101
   PubMed Web of Science ®Google Scholar
• Carnaille B., Oudar C., Pattou F., Quievreux J., Proye C. Improvements in parathyroid surgery in the intact 1–84 PTH assay era. Aust N Z J Surg 1998; 68: 112
   PubMedGoogle Scholar
• Chan A. K., Duh Q. Y., Katz M. H., Siperstein A. E., Clark O. H. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 1995; 222: 412
   Web of Science ®Google Scholar
• Chattopadhyay N., Mithal A., Brown E. M. The calcium-sensing receptor: A window to the physiology and pathophysiology of mineral ion metabilism. Endocr Rev 1996; 17: 289
   PubMed Web of Science ®Google Scholar
• Chigot J. P., Menegaux F., Achrafi H. Should primary hyperparathyroidism be treated surgically in patients older than 75 years?. Surgery 1995; 117: 397
   PubMed Web of Science ®Google Scholar
• Chou F. F., Shen-Chen S. M., Leong C. P. Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism. Surgery 1995; 117: 18
   PubMed Web of Science ®Google Scholar
• Christensson T. Menopausal age of females with hypercalcemia. Acta Med Scand 1976; 200: 361
   PubMedGoogle Scholar
• Christensson T., Hellström K., Wengle B., Alveryd A., Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1976A; 200: 131
   PubMedGoogle Scholar
• Christensson T., Hellström K., Wengle B. Clinical and laboratory findings in subjects with hypercalcemia: A study including cases with primary hyperparathyroidism detected in a health screening. Acta Med Scand 1976B; 200: 355
   PubMedGoogle Scholar
• Christensson T. Serum urate in subjects with hypercalcemic hyperparathyroidism. Clin Chim Acta 1977; 80: 529
   PubMed Web of Science ®Google Scholar
• Christensson T., Einarsson K. Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism. Clin Chim Acta 1977; 78: 411
   PubMed Web of Science ®Google Scholar
• Christensson T., Hellström K., Wengle B. Blood pressure in subjects with hypercalcemia and primary hyperparathyroidism detected in a health screening programme. Eur J Clin Invest 1977; 7: 109
   PubMed Web of Science ®Google Scholar
• Christensson T. A.T. Primary hyperparathyroidism - pathogenesis, incidence and natural history. Parathyroid Surgery, Progress in Surgery, M. Rothmund, S A Wells, Jr. Karger, Basel 1986; 34
   Google Scholar
• Christiansen P., Steiniche T., Vesterby A., Mosekilde L., Hessov I., Melsen F. Primary hyperparathyroidism: Iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992; 13: 41
   PubMed Web of Science ®Google Scholar
• Christiansen P., Steiniche T., Brixen K., Hessov I., Melsen F., Charles P., Mosekilde L. Primary hyperparathyroidism: Biochemical markers and bone density at multiple skeletal sites in Danish patients. Bone 1997; 1: 93
   Google Scholar
• Clark O. H., Wilkes W., Siperstein A. E., Duh Q. Y. Diagnosis and management of asymptomatic hyperparathyroidism: Safety, efficacy and deficiency in our knowledge. J Bone Miner Res 1991; 6: 135
   Google Scholar
• Clark O. H. Asymptomatic primary hyperparathyroidism. Is parathyroidectomy indicated?. Surgery 1994; 116: 947
   PubMed Web of Science ®Google Scholar
• Clark O. H. Surgical treatment of primary hyperparathyroidism. Adv Endocrinol Metab 1995; 6: 1
   PubMedGoogle Scholar
• Cogan M. G., Covey C. M., Arieff A. I., Wisniewski A., Clark O. H., Lazarowitz V., Leach W. Central nervous system manifestations of hyperparathyroidism. Am J Med 1978; 65: 963
   PubMed Web of Science ®Google Scholar
• Colliander E. B., Strigard K., Westblad P., Rolf C., Nordenström J. Muscle strength and endurance after surgery for primary hyperparathyroidism. Eur J Surg 1998; 164: 489
   PubMedGoogle Scholar
• Corlew D. S., Bryda S. L., Bradley E. L., DiGirolamo M. Observations on the course of untreated primary hyperparathyroidism. Surgery 1985; 98: 1064
   PubMed Web of Science ®Google Scholar
• Corsello S. M., Folli G., Crucitti, Della Casa S., Rota C. A., Tofani A., Colasanti S., Barbarino A. Acute complications in the course of “mild” hyperparathyroidism. J Endocrinol Invest 1991; 14: 971
   PubMed Web of Science ®Google Scholar
• Cosman F., Shen V., Xie F., Seibel M., Ratcliffe A., Lindsay R. Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Ann Int Med 1993; 118: 337
   PubMed Web of Science ®Google Scholar
• Cros M., Silve C., Graulet A. M., Morieux C., Urena P., de Vernejoul M. C., Bouizar Z. Estrogen stimulates PTHrP but not PTH/PTHrP receptor gene expression in the kidney of ovariectomized rat. J Cell Biochem 1998; 70: 84
   PubMed Web of Science ®Google Scholar
• Dalberg K., Brodin L. A., Juhlin-Dannfelt A., Farnebo L. O. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 1996; 162: 171
   PubMedGoogle Scholar
• Davies M. Current therapy. Primary hyperparathyroidism: Aggressive or conservative treatment?. Clin Endocrinol 1992; 36: 325
   PubMed Web of Science ®Google Scholar
• Davis J. W., Ross P. D., Wasnich R. D., MacLean C. J., Vogel J. M. Long-term precision of bone loss rate measurements among postmenopausal women 1991; 48: 311
   Google Scholar
• Delbridge L. W., Marshman D., Reeves T. S., Crummer P., Posen S. Neuromuscular symptoms in elderly patients with hyperparathyroidism: Improvement with parathyroid surgery. Med J Aust 1988; 149: 74
   PubMed Web of Science ®Google Scholar
• Delbridge L. W., Younnes N. A., Guinea A. I., Reeve T. S., Clifton-Bligh P., Robinson B. G. Surgery for primary hyperparathyroidism 1962 - 1996: Indications and outcomes. Med J Aust 1998; 16: 153
   Google Scholar
• Demay M. B., Kiernan M. S., DeLuca H. F., Kronenberg H. M. Sequences in the parathyroid hormone gene that bind the 1,25-dihydroxyvitamine D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamine D3. Proc Natl Acad Sci USA 1992; 89: 8097
   PubMed Web of Science ®Google Scholar
• Dempster D. W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993; 14: 690
   PubMed Web of Science ®Google Scholar
• Dent D. M., Miller J. L., Klaff L., Barron J. The incidence and causes of hypercalcemia. Postgrad Med J 1987; 63: 745
   PubMed Web of Science ®Google Scholar
• Derogatis L. R., Lipman R. S., Rickels K., Uhlenhuth E. H., Covi L. The Hopkins symptom checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974; 19: 1
   PubMedGoogle Scholar
• Diamond T., Ng A. T.M., Levy S., Margarey C., Smart R. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: A preliminary report. Osteoporos Int 1996; 6: 329
   PubMed Web of Science ®Google Scholar
• Dubovsky S. L., Franks R. D. Intracellular calcium ions in affective disorders: A review and a hypothesis. Biol Psychiatry 1983; 18: 781
   PubMed Web of Science ®Google Scholar
• Duh Q. Y., Arnaud C. D., Levin K. E., Clark O. H. Parathyroid hormone: Before and after parathyroidectomy. Surgery 1986; 100: 1021
   PubMed Web of Science ®Google Scholar
• Eastell R., Yergey A. L., Vieira N. E., Cedel S. L., Kumar R., Riggs B. L. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 1991; 6: 125
   PubMed Web of Science ®Google Scholar
• Eitinger L. Hyperparatyreoidisme og psykiske forandringar. Nord Med 1942; 14: 1581
   Google Scholar
• Elvius M., Lagrelius A., Nygren Å, Alveryd A., Christenson T. A.T., Nordenström J. Seventeen-year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg 1995; 161: 863
   PubMedGoogle Scholar
• Epstein P. A., Prentki M., Attie M. F. Modulation of intracellular Ca2+ in the parathyroid cell. Release of Ca2+ from non-mitochondrial pools by inositol triphosphate. FEBS Lett 1985; 188: 144
   Web of Science ®Google Scholar
• Falco J. M., Guy J. T., Smith R. E., Mazzaferri E. L. Primary hyperparathyrodism and anemia. Arch Int Med 1976; 136: 887
   PubMedGoogle Scholar
• Falkheden T., Ohlsson L., Sjögren B. Renal function in primary hyperparathyroidism. A follow-up study two to eleven years after surgery comprising 139 patients. Scand J Urol Nephrol 1980; 14: 167
   PubMed Web of Science ®Google Scholar
• Finkelstein J. S., Klibanski A., Schaefer E. H., Hornstein M. D., Schiff I., Neer R. M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 1994; 15: 331
   Google Scholar
• Fliser D., Stefanski A., Franek E., Fode P., Gudarzi A., Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997A; 27: 629
   PubMed Web of Science ®Google Scholar
• Fliser D., Franek E., Fode P., Stefanski A., Schmitt C. P., Lyons M., Ritz E. Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 1997B; 12: 933
   PubMed Web of Science ®Google Scholar
• Foulks C. J., Mills G. M., Wright L. F. Parathyroid hormone and anemia - an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism. Postgrad Med J 1989; 65: 136
   PubMed Web of Science ®Google Scholar
• Frolich A. Prevalence of hypercalcemia in normal and in hospital populations. Dan Med Bull 1998; 45: 436
   PubMed Web of Science ®Google Scholar
• Gallagher J. C., Nordin B. E.C. Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women. Lancet 1972; i: 503
   Google Scholar
• Gallagher J. C., Nordin B. E.C. Effects of estrogen and progestogen therapy on calcium metabolism in postmenopausal women. Estrogens in postmenopause. Frontiers of Hormone Research 1975; 3: 150
   PubMedGoogle Scholar
• Gallagher J. C., Goldgar D., Moy A. Total bone calcium in normal women. Effect of menopausal status. J Bone Miner Res 1987; 2: 491
   PubMed Web of Science ®Google Scholar
• Gallagher J. C., Kinyamu K. H., Fowler S. E., Dawson-Hughes B., Dalsky G. P., Sherman S. S. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 1998; 13: 475
   PubMed Web of Science ®Google Scholar
• Gaz R. D., Wang C. Management of asymptomatic hyperparathyroidism. Am J Surg 1984; 147: 498
   PubMed Web of Science ®Google Scholar
• Glendenning P., Gutteridge D. H., Retallack R. W., Stuckey B. G., Kermode D. G., Kent G. N. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: A challenge to current diagnostic criteria. Aust N Z J Med 1998; 28: 173
   PubMedGoogle Scholar
• Grey A. B., Evans M. C., Stapleton J. P., Reid I. R. Body weight and bone mineral density in post-menopausal women with primary hyperparathyroidism. Ann Intern Med 1994; 121: 745
   PubMed Web of Science ®Google Scholar
• Grey A. B., Stapleton J. P., Evans M. C., Tatnell M. A., Reid I. R. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Int Med 1996A; 125: 360
   PubMed Web of Science ®Google Scholar
• Grey A. B., Stapleton J. P., Evans M. C., Reid I. R. Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin Endocrinol 1996B; 44: 697
   PubMed Web of Science ®Google Scholar
• Grey A. B. The skeletal effects of primary hyperparathyroidism. Baillieres Clin Endocrinol Metab 1997; 11: 101
   PubMedGoogle Scholar
• Grimelius L., Åkerström G., Johansson H., Juhlin C., Rastad J. The parathyroid glands. Functional Endocrine Pathology, K. Kovacs, S. L. Asa. Blackwell Science Inc, Oxford 1998; 381
   Google Scholar
• Groth T. L., Ljunghall S., DeVerdier C. H. Optimal screening for patients with hyperparathyroidism with use of serum calcium observations: A decision-theoretical analysis. Scand J Clin Lab Invest 1983; 43: 699
   PubMed Web of Science ®Google Scholar
• Grotz W. H., Rump L. C., Niessen A., Schmidt-Gayk H., Reichelt A., Kirste G., Olschewski M., Schollmeyer P. J. Treatment of osteopenia and osteoporosis after kidney transplantation. Transplant 1998; 66: 1004
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440
   PubMed Web of Science ®Google Scholar
• Gunn I. R., Wallace J. R. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in diagnosis of primary hyperparathyroidism and familial benign hypercalcemia. Ann Clin Biochem 1992; 29: 52
   PubMed Web of Science ®Google Scholar
• Guo C. Y., Thomas W. E., Al-Dehaimi A. W., Assiri A. M., Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 3487
   PubMed Web of Science ®Google Scholar
• Haight R. O., Temple T. E., Jr, Garret R. G., Marsland D. W. Primary hyperparathyroidism in the primary care setting. J Fam Pract 1976; 3: 257
   PubMedGoogle Scholar
• Haldimann B., Trechsel U., Dambacher M. A., Flury W. Hyperparathyroidie primaire de la femme agee: Effet des oestrogenes sur la metabolisme calcique. Schweiz Med Wochenschr 1982; 112: 1242
   PubMedGoogle Scholar
• Harman C. R., Grant C. S., Hay I. D., Hurley D. L., van Heerden J. A., Thompson G. B., Reading C. C., Charboneau J. W. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998; 124: 1011
   PubMed Web of Science ®Google Scholar
• Harrison B. J., Wheeler M. H. Asymptomatic primary hyperparathyroidism. World J Surg 1991; 15: 724
   PubMed Web of Science ®Google Scholar
• Heany R. P., Recker R. R., Saville P. D. Menopausal changes in bone remodeling. J Lab Clin Med 1978; 92: 964
   PubMed Web of Science ®Google Scholar
• Heath D. A. Primary hyperparathyroidism. Clinical presentation and factors influencing clinical management. Endocrinol Metab Clin North Am 1989; 18: 631
   PubMed Web of Science ®Google Scholar
• Heath D. A., Heath E. M. Conservative management of primary hyperparathyroidism. J Bone Miner Res 1991; 6: 117
   PubMedGoogle Scholar
• Heath H., Hodgson S. F., Kennedy M. A. Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302: 189
   PubMed Web of Science ®Google Scholar
• Heath H., Purnell D. C. Asymptomatic hypercalcemia and primary hyperparathyroidism. Calcium Disorders. Clinical Endocrinology, D. Heath, D. J. Marx. Butterworth, London 1982; vol 2: 189
   Google Scholar
• Heath H. Clinical spectrum of primary hyperparathyroidism: Evolution with changes in medical practice and technology. J Bone Miner Res 1991; 6: 63
   Google Scholar
• Hedbäck G., Tisell L.-E., Bengtsson B-Å, Hedman I., Odén A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 1990; 14: 829
   PubMed Web of Science ®Google Scholar
• Hedbäck G., Ode'n A. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991; 15: 399
   PubMed Web of Science ®Google Scholar
• Hedbäck G., Ode'n A. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur Clin invest 1995; 25: 48
   PubMed Web of Science ®Google Scholar
• Hedbäck G., Ode'n A. Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest 1998A; 28: 271
   PubMed Web of Science ®Google Scholar
• Hedbäck G., Ode'n A. Death risk factor analysis in primary hyperparathyroidism. Eur J Clin Invest 1998B; 28: 1011
   PubMed Web of Science ®Google Scholar
• Hedman I., Grimby G., Tisell L. E. Improvement of muscle strength after treatment for hyperparathyroidism. Acta Chir Scand 1984; 150: 521
   PubMedGoogle Scholar
• Hellman P., Öhrvall U., Rudberg C., Bjerneroth G., Juhlin C., Grimelius L., Ridefelt P., Åkerström G., Rastad J. Incidence, structure, and function of enlarged parathyroid glands discovered accidentally during thyroid surgery. Surgery 1992; 113: 655
   Web of Science ®Google Scholar
• Herbai G., Ljunghall S. Normalization of hypercalcemia of primary hyperparathyroidism by treatment with methallenestril, a syntetic oestrogen with low oestrogenicity. Urol Int 1983; 38: 371
   PubMed Web of Science ®Google Scholar
• Herbai G., Ljunghall S. Treatment of primary hyperparathyroidism with cyclofenil - a synthetic stilbestrol derivate with minimal feminizing effects. Horm Metab Res 1984; 16: 374
   PubMed Web of Science ®Google Scholar
• Hock J. M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 1992; 7: 65
   PubMed Web of Science ®Google Scholar
• Hodsman A. B., Fraher L. J., Watson P. H., Ostbye T., Stitt L. W., Adachi J. D., Taves D. H., Drost D. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 1997; 82: 620
   PubMed Web of Science ®Google Scholar
• Horowitz M., Wishart J., Need A. G., Morris H., Philcox J., Nordin B. E.C. Treatment of postmenopausal hyperparathyroidism with norethidrone. Effects on biochemistry and forearm mineral density. Arch Intern Med 1987; 147: 681
   PubMedGoogle Scholar
• Hulter H. N., Melby J. C., Peterson J. C., Cooke C. R. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986; 2: 360
   PubMedGoogle Scholar
• Hörnquist J. O., Hansson B., Leijon M., Mikaelsson B. Repeated short-term sick-leave and quality of life. Scand J Soc Med 1990; 18: 91
   PubMedGoogle Scholar
• Jansson S., Grimby G., Hagne I., Hedman I., Tisell L-E. Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur J Surg 1991A; 157: 13
   PubMedGoogle Scholar
• Jansson S., Tisell L. E., Lindstedt G., Lundberg P. A. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Surgery 1991B; 110: 480
   PubMed Web of Science ®Google Scholar
• Jimerson D. C., Wood J. H., Post R. M. Cerbrospinal fluid calcium. Clinical correlates in psychiatric and seizure disorders. Neurobiology of CSF, J. H. Wood. Plenum Press, New York 1980; 743
   Google Scholar
• Joborn C., Hetta J., Palmér M., Åkerström G., Ljunghall S. Psychiatric symptomatology in patients with primary hyperparathyroidism. Upsala J Med Sci. 1986A; 91: 77
   PubMed Web of Science ®Google Scholar
• Joborn C., Hetta J., Frisk P., Palmér M., Åkerström G., Ljunghall S. Primary hyperparathyroidism in patients with organic brain syndrome. Acta Med Scand 1986B; 219: 91
   PubMedGoogle Scholar
• Joborn C., Hetta J., Rastad J., Ågren H., Åkerström G., Ljunghall S. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiat 1988A; 23: 149
   PubMed Web of Science ®Google Scholar
• Joborn C., Joborn H., Rastad J., Åkerström G., Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 1988B; 75: 77
   PubMed Web of Science ®Google Scholar
• Joborn C., Hetta J., Lind L., Rastad J., Åkerström G., Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing hypercalcemia. Surgery 1989A; 105: 72
   PubMed Web of Science ®Google Scholar
• Joborn C., Rastad J., Stålberg E., Åkerström G., Ljunghall S. Muscle function in patients with primary hyperparathyroidism. Muscle Nerve 1989B; 12: 87
   PubMed Web of Science ®Google Scholar
• Joborn C., Ljunghall S., Larsson K., Lindh E., Naessén T., Wide L., Åkerström G., Rastad J. Skeletal responsiveness to parathyroid hormone in healthy females: Relationship to menopause and oestrogen replacement. Clin Endocrinol 1991A; 34: 335
   PubMed Web of Science ®Google Scholar
• Joborn C., Hetta J., Niklasson F., Rastad J., Wide L., Ågren H., Åkerström G., Ljunghall S. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites, and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinol 1991B; 16: 311
   PubMed Web of Science ®Google Scholar
• Johansson H., Thorén L., Werner I., Grimelius L. Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery 1975; 77: 691
   PubMed Web of Science ®Google Scholar
• Juhlin C., Klareskog L., Nygren P., Ljunghall S., Gylfe E., Rastad J., Åkerström G. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 1988; 122: 2999
   PubMed Web of Science ®Google Scholar
• Juhlin C., Rastad J., Klareskog L., Grimelius L., Åkerström G. Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am J Pathol 1989; 135: 321
   PubMed Web of Science ®Google Scholar
• Jüppner H., Rosenblatt M., Segre G. V., Hesch R. D. Discrimination between intact and mid-C regional PTH using selective radioimmuneassay systems. Acta Endocrinol 1983; 102: 543
   Google Scholar
• Kadowaki S., Norman A. W. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 1984; 73: 759
   PubMed Web of Science ®Google Scholar
• Karpati G., Frame B. Neuropsychiatric disorders in primary hyperparathyroidism. Arch Neurol 1964; 10: 387
   PubMed Web of Science ®Google Scholar
• Karstrup S., Hegedus L., Holm H. H. Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas. Acta Endocrinol 1993; 129: 377
   PubMedGoogle Scholar
• Kenny A. M., MacGillivray D. C., Pilbeam C. C., Crombie H. D., Raisz L. G. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 1995; 118: 109
   PubMed Web of Science ®Google Scholar
• Kleeman C. R., Norris K., Coburn J. W. Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamine D status of the patient?. Miner Electrolyte Metab 1987; 13: 305
   PubMedGoogle Scholar
• Kleerekoper M. Clinical course of primary hyperparathyroidism. In The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994A; 471, Ch 27
   Google Scholar
• Kleerekoper M., Bilezikian J. P. A cure in search of a disease: Parathyroidectomy for nontraditional features of primary hyperparathyroidism. Am J Med 1994B; 96: 99
   PubMed Web of Science ®Google Scholar
• Klimiuk P. S., Davies M., Adams P. H. Primary hyperparathyroidism and thiazide diuretics. Postgrad Med J 1981; 57: 80
   PubMed Web of Science ®Google Scholar
• Klugman V. A., Favus M. J., Pak C. Y.C. Nephrolithiasis in primary hyperparathyroidism. The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 505, Ch 30
   Google Scholar
• Kristoffersson A., Boquist L., Holmlund D., Järhult J. Long term effects of surgery for normocalcaemic hyperparathyroidism. Acta Chir Scand 1987; 153: 331
   PubMedGoogle Scholar
• Kristoffersson A., Bjerle P., Sthernberg N. Pre- and postoperative respiratory muscle strength in primary hyperparathyroidism. Acta Chir Scand 1988; 154: 415
   PubMedGoogle Scholar
• Kristoffersson A., Boström A., Söderberg T. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 1992; 79: 165
   PubMed Web of Science ®Google Scholar
• Kumar S., Olukoga A. O., Gordon C., Mawer E. B., France M., Hosker J. P., Davies M., Boulton A. J.M. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1994; 40: 47
   PubMed Web of Science ®Google Scholar
• Ladenson J. H. Blood calcium determination in primary hyperparathyroidism. J Bone Miner Res 1991; 6: 33
   Google Scholar
• Lafferty F. W. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med 1981; 141: 1761
   PubMed Web of Science ®Google Scholar
• Lafferty F. W., Hubay C. A. Primary hyperparathyroidism. A review of long-term surgical and non-surgical morbidities as a basis for a rational approach to treatment. Arch Intern Med 1989; 149: 789
   PubMedGoogle Scholar
• Lafferty F. W. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991; 6: 51
   PubMedGoogle Scholar
• Larsson K., Lindh E., Lind L., Persson I., Ljunghall S. Increased fracture risk in hypercalcemia: Bone mineral content measured in hyperparathyroidism. Acta Orthop Scand 1989; 60: 268
   PubMed Web of Science ®Google Scholar
• Larsson K., Ljunghall S., Krusemo U. B., Naessén T., Lindh E., Persson I. The risk of hip fractures in patients with primary hyperparthyroidism: A populationbased cohort study with 19 years follow-up. J Int Med 1993; 234: 585
   PubMed Web of Science ®Google Scholar
• Larsson R., Wallfelt C., Abrahamsson H., Gylfe E., Ljunghall S., Rastad J., Rorsman P., Wide L., Åkerström G. Defective regulation of the cystosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidism. Biosci Rep 1984; 4: 909
   PubMed Web of Science ®Google Scholar
• Leifsson B. G., Ahre'n B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 1996; 81: 2149
   PubMed Web of Science ®Google Scholar
• Lidbrink E., Frisell J., Brandberg Y., Rosendahl I., Rutqvist L.-E. Nonattendance in the Stockholm mammography screening trial: Relative Mortality and reason for nonattendance. Cancer Res Treatm 1995; 35: 267
   Web of Science ®Google Scholar
• Liel Y., Shany S., Smirnoff P., Schwartz B. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 1999; 140: 280
   PubMed Web of Science ®Google Scholar
• Lind L., Jacobsson S., Palmér M., Lithell H., Wengle B., Ljunghall S. Cardiovascular risk factors in primary hyperparathyroidism: A 15-year follow-up of operated and unoperated cases. J Intern Med 1991; 230: 29
   PubMed Web of Science ®Google Scholar
• Lind L., Ljunghall S. Serum urate and renal function in different forms of hypercalcemia. Exp Clin Endocrinol 1992; 99: 87
   PubMedGoogle Scholar
• Lind L., Wengle B., Lithell H., Ljunghall S. Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol). J Intern Med 1992; 231: 427
   PubMed Web of Science ®Google Scholar
• Lind L., Ljunghall S. Hypertension, primary hyperparathyroidism and the parathyroid hypertensive factor. Blood Press 1993; 2: 4
   PubMedGoogle Scholar
• Lind L., Ridefelt P., Rastad J., Åkerström G., Ljunghall S. Relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism. J Hum Hypertens 1994; 8: 113
   PubMed Web of Science ®Google Scholar
• Lind L., Ljunghall S. Parathyroid hormone and blood pressure - is there a relationship?. Nephrol Dial Transplant 1995A; 10: 450
   PubMed Web of Science ®Google Scholar
• Lind L., Ljunghall S. Pre-operative evaluation of risk factors for complications in patients with primary hyperparathyroidism. Eur J Clin Invest 1995B; 25: 955
   PubMed Web of Science ®Google Scholar
• Lind L., Skarfors E., Berglund L., Lithell H., Ljunghall S. Serum calcium: A new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997; 50: 967
   PubMed Web of Science ®Google Scholar
• Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. Osteoporosis: Etiology, Diagnosis, and Management, B. L. Riggs, L. J. Melton. Raven Press, New York 1988; 333
   Google Scholar
• Lindsay R., Nieves J., Formica C., Henneman E., Woelfert L., Shen V., Dempster D., Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestropgen with osteoporosis. Lancet 1997; 350: 550
   PubMed Web of Science ®Google Scholar
• Lindstedt G., Nyström E., Lundberg P.-A., Johansson E., Eggertsen R. Screening of an elderly population in primary care for primary hyperparathyroidism. Scand J Prim Health Care 1992; 10: 192
   PubMedGoogle Scholar
• Lins L. E. Renal function in primary hyperparathyroidism and in non-parathyroid hypercalcemia. Acta Med Scand 1979; 205: 607
   PubMedGoogle Scholar
• Ljungdahl L. O., Bjurulf P. The accordance of diagnoses in a computerized sick-leave register with doctor's certificates and medical records. Scand J Soc Med 1991; 19: 148
   PubMedGoogle Scholar
• Ljunghall S., Lithell H., Vessby B., Wide L. Glucose and lipoprotein metabolism in primary hyperparathyroidism. effects of parathyroidectomy. Acta Endocrinol 1978; 89: 580
   PubMedGoogle Scholar
• Ljunghall S., Källsen R., Backman U., Danielson B. G., Grimelius L., Johansson H., Thorén L., Werner I. Clinical effects of parathyroid surgery in normocalcemic patients with recurrent renal stones. Acta Chir Scand 1980; 146: 161
   PubMedGoogle Scholar
• Ljunghall S., Åkerström G. Urate metabolism in primary hyperparathyroidism. Urol Int 1982; 37: 73
   PubMed Web of Science ®Google Scholar
• Ljunghall S., Palmér M., Åkerström G., Wide L. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 1983; 13: 373
   PubMed Web of Science ®Google Scholar
• Ljunghall S., Åkerström G., Johanssson G., Olsson Y., Stålberg F. Neuromuscular involvement in primary hyperparathyroidism. J Neurol 1984; 231: 263
   PubMed Web of Science ®Google Scholar
• Ljunghall S., Hällgren R., Rastad J. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism. Expl Clin Endocrinol 1985; 86: 218
   PubMedGoogle Scholar
• Ljunghall S., Joborn C., Palmér M., Rastad J., Åkerström G. Primary hyperparathyroidism - the surgically cured patient. Clinical Disorders of Bone Mineral Metabolism, M. Kleerekoper, S. M. Krane. Mary Ann Liebert Inc Publ, N.Y. 1989; 353
   Google Scholar
• Ljunghall S., Jakobsson S., Joborn C., Palmér M., Rastad J., Åkerström G. Longitudinal studies of mild primary hyperparathyroidism. J Bone Miner Res 1991A; 6: 111
   Google Scholar
• Ljunghall S., Hellman P., Rastad J., Åkerström G. Primary hyperparathyroidism: Epidemiology, diagnosis and clinical picture. World J Surg 1991B; 15: 681
   PubMed Web of Science ®Google Scholar
• Ljunghall S., Larsson K., Lindh E., Lindqvist U., Rastad J., Åkerström G., Wide L. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. Surgery 1991C; 110: 47
   PubMed Web of Science ®Google Scholar
• Lloyd H. M. Primary hyperparathyroidism: An analysis of the role of the parathyroid tumor. Medicine (Baltimore) 1968; 47: 53
   PubMed Web of Science ®Google Scholar
• Lundgren E., Rastad J., Ridefelt P., Juhlin C., Åkerström G., Ljunghall S. Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. Surgery 1992; 112: 1123
   PubMed Web of Science ®Google Scholar
• MacDonald B. R., Gallagher J. A., Russel R. G.G. Parathyroid hormone stimulates the proliferation of cells derived from human bone. Endocrinology 1986; 118: 2445
   PubMed Web of Science ®Google Scholar
• MacDonald P. N., Ritter C., Brown A., Slatopolsky E. Retinoic acid suppresses parathyroid hormone (PTH) secretion and preproPTH mRNA levels in bovine parathyroid cell culture. J Clin Invest 1994; 93: 725
   PubMed Web of Science ®Google Scholar
• Malette L. E., Bilezikian J. P., Heath D. A., Aurbach G. D. Primary hyperparathyroidism: Clinical and biochemical features. Medicine 1974; 53: 127
   PubMed Web of Science ®Google Scholar
• Malmaeus J., Granberg P. O., Halvorsen J., Åkerström G., Johansson H. Parathyroid surgery in Scandinavia. Acta Chir Scand 1988; 154: 409
   PubMedGoogle Scholar
• Mallmin H., Ljunghall S., Larsson K., Lindh E. Screening for primary hyperparathyroidism in patients with fractures of the distal forearm. Eur J Surg 1991; 157: 657
   Google Scholar
• Mandl F. Therapeutischer Versuch bei Ostitis fibrosa generalisata mittels Extirpation eines Epithelkörperchentumors. Wien klin Wochenschr 1925; 50: 1343
   Google Scholar
• Marcus R. Estrogens and progestins in the management of primary hyperparathyroidism. J Bone Miner Res 1991; 6: 125
   PubMedGoogle Scholar
• Marcus R., Madvig P., Crim M., Pont A., Kosek J. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med 1984; 100: 633
   PubMed Web of Science ®Google Scholar
• Marcus R. Normal and abnormal bone remodeling in man. Ann Rev Med 1987; 38: 129
   PubMed Web of Science ®Google Scholar
• Martin P., Bergmann P., Gillet C., Fuss M., Kinnaert P., Corvilain J., van Geertruyden J. Partial reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 1986; 146: 689
   PubMedGoogle Scholar
• Martin P., Bergmann P., Gillet C., Fuss M., Corvilain J., van Geertruyden J. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med 1990; 150: 1495
   PubMedGoogle Scholar
• Mautalen C., Reyes H. R., Ghiringhelli G., Fromm G. Cortical bone mineral content in primary hyperparathyroidism: changes after parathyroidectomy. Acta Endocrinol (Copenhagen) 1986; 111: 494
   PubMedGoogle Scholar
• McAllion S. J., Paterson C. R. Psychiatric morbidity in primary hyperparathyroidism. Postgrad Med J 1989; 65: 628
   PubMed Web of Science ®Google Scholar
• McDermott M. T., Perloff J. J., Kidd G. S. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 1994; 9: 509
   PubMed Web of Science ®Google Scholar
• McKane W. R., Khosla S., Burritt M. F., Kao P. C., Wilson D. M., Ory S. J., Riggs B. L. Mechanism of renal calcium conservation with oestrogen replacement therapy in women in early post-menopause - a clinical research center study. J Clin Endocrinol Metab 1995; 80: 3458
   PubMed Web of Science ®Google Scholar
• Melton L. J., III, Atkinson E. J., O'Fallon W. M., Heath H, III. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992; 152: 2269
   PubMedGoogle Scholar
• Miccoli P., Bendinelli C., Vignali E., Mazzeo S., Cecchini G. M., Pinchera A., Marcocci C. Endoscopic parathyroidectomy: report of an initial experience. Surgery 1998A; 124: 1077
   PubMed Web of Science ®Google Scholar
• Miccoli P., Bendinelli C., Conte M., Pinchera A., Marcocci C. Endoscopic parathyroidectomy by a gasless approach. J Laparoendosc Adv Surg Tech 1998B; 8: 189
   PubMed Web of Science ®Google Scholar
• Mitlak B. H., Daly M., Potts J. T., Jr, Schoenfeld D., Neer R. M. Asymptomatic primary hyperparathyroidism. J Bone Min Res 1991; 6: 103
   PubMedGoogle Scholar
• Mollerup C. L., Lindewald H. Renal stones and primary hyperparathyroidism: natural history of renal stone disease after successful parathyroidectomy. World J Surg 1999; 23: 173
   PubMed Web of Science ®Google Scholar
• Mundy G. R., Cove D. H., Fisken R. Primary hyperparathyroidism: Changes in the pattern of clinical presentation. Lancet 1980; i: 1317
   Google Scholar
• Nemeth E. F., Scarpa A. Receptor-dependent mobilization of cellular Ca2+ and the regulation of hormone secretion in parathyroid cells. Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects, D. V. Cohn, T. J. Martin, P. J. Meunier. Elsevier, Amsterdam 1987; vol. 9: 167
   Google Scholar
• Neunteufl T., Katzenschlager R., Abela C., Köstner K., Niederle B., Weidinger F., Stefenelli T. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998; 40: 396
   PubMed Web of Science ®Google Scholar
• Niederle B., Stefenelli T., Glogar D., Woloszczuk W., Roka R., Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery 1990; 108: 1052
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Conference Statement. J Bone Miner Res 1991; 6: 9
   PubMed Web of Science ®Google Scholar
• Nordin B. E.C., Cleghorn D. B., Chatterton B. E., Morris H. A., Need A. G. A 5-year longitudinal study of forearm bone mass in 307 postmenopausal women. J Bone Miner Res 1993; 8: 1427
   PubMed Web of Science ®Google Scholar
• Norman A. W., Frankel J. B., Heldt A. M., Grodsky G. M. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823
   PubMed Web of Science ®Google Scholar
• Norman J., Chheda H., Farell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: Decreasing operative time and potential complications while improving cosmetic results. Am Surg 1998; 64: 391
   PubMed Web of Science ®Google Scholar
• Numann P. J., Torppa A. J., Blumetti A. E. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery 1984; 96: 1119
   PubMed Web of Science ®Google Scholar
• Nussbaum S. R., Gaz R. D., Arnold A. Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 1990; 323: 1324
   PubMed Web of Science ®Google Scholar
• Nussbaum S. R. Sensitive immunometric assays for parathyroid hormone and their impact on the diagnosis and management of hyperparathyroidism. J Bone Miner Res 1991; 6: 43
   Google Scholar
• Nussbaum S. R., Potts J. T. Advances in immunoassays for parathyroid hormone: clinical applications to skeletal disorders of bone and mineral metabolism. The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 157, Ch 11
   Google Scholar
• Nygren P., Larsson R., Johansson H., Ljunghall S., Rastad J., Åkerström G. 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int 1988; 43: 213
   PubMed Web of Science ®Google Scholar
• Nyomba B. L., Auwerx J., Bormans V., Peeters T. L., Pelemans W., Reynaert J., Bouillon R., Vantrappen G., De Moor P. Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 1986; 29: 34
   PubMed Web of Science ®Google Scholar
• Nyomba B. L., Bouillon R., De Moor P. Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 1984; 115: 191
   PubMed Web of Science ®Google Scholar
• Nyström L., Rutqvist L. E., Wall S., Lindgren A., Lindqvist M., Ryden S., Andersson J., Bjurstam N. Breast cancer screening with mammography: Overview of Swedish randomised trials. Lancet 1993; 341: 973
   PubMed Web of Science ®Google Scholar
• Okamoto T., Gerstein H. C., Obara T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: A systematic overview of the literature. Endocr J 1997; 44: 367
   PubMed Web of Science ®Google Scholar
• Palmér M., Adami H.-O., Bergström R., Jakobsson S., Åkerström G., Ljunghall S. Survival and renal function in persons with untreated hypercalcemia: a population-based cohort study with 14 years of follow-up. Lancet 1987A; i: 59
   Google Scholar
• Palmér M., Ljunghall S., Åkerström G., Adami H.-O., Bergström R., Grimelius L., Rudberg C., Johansson H. Patients with primary hyperparathyroidism operated on over a 24-year period: Temporal trends of clinical and laboratory findings. J Chron Dis 1987B; 40: 121
   PubMedGoogle Scholar
• Palmér M., Jacobsson G., Åkerström G., Ljunghall S. Prevalence of hypercalcemia in a health survey: A 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988A; 18: 39
   PubMed Web of Science ®Google Scholar
• Palmér M., Adami H.-O., Krusemo U. B., Ljunghall S. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. Am J Epidemiol 1988B; 127: 1031
   PubMed Web of Science ®Google Scholar
• Pang P. K., Janssen H. F., Yee J. A. Effects of synthetic parathyroid hormone on vascular beds of dogs. Pharmacology 1980; 21: 213
   PubMed Web of Science ®Google Scholar
• Parfitt A. M. The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I: Mechanisms of calcium transfer between blood and bone and their cellular basis: Morphological and kinetic approaches to bone turnover. Metabolism 1976; 25: 809
   PubMed Web of Science ®Google Scholar
• Parfitt A. M. Equilibrium and disequilibrium hypercalcemia: A new light on an old concept. Metab Bone Dis Relat Res 1979; 1: 279
   Google Scholar
• Parfitt A. M. The physiologic and clinical significance of bone histmorphometric data. Bone Histomorphometry, Techniques and Interpretation, R. R. Recker. CRC Press Inc, Boca Raton, Florida 1983; 143
   Google Scholar
• Parfitt A. M. Surface specific bone remodeling in health and disease. Clinical Disorders of Bone and Mineral Metabolism, M. Kleerekoper, S. Krane. Mary Ann Liebert, New York 1987; 7
   Google Scholar
• Parfitt A. M. Bone remodeling: Relationship to the amount and structure of bone, and the pathogenesis and prevention of fractures. Osteoporosis: Etiology, Diagnosis, and Management, B. L. Riggs. Raven Press, New York 1988; 45
   Google Scholar
• Parfitt A. M., Rao D. S., Kleerekoper M. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 1991; 6: 97
   Google Scholar
• Parfitt A. M. Parathyroid growth: Normal and abnormal. The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 373, Ch 23
   Google Scholar
• Parfitt A. M. Hormonal influences on bone remodeling and bone loss: Application to the management of primary hyperparathyroidism. Ann Intern Med 1996; 125: 413
   PubMed Web of Science ®Google Scholar
• Parfitt A. M., Fyhrie D. P. Gompertzian growth curves in parathyroid tumours: Further evidence for the set-point hypothesis. Cell Prolif 1997; 30: 341
   PubMed Web of Science ®Google Scholar
• Parisien M., Silverberg S. J., Shane E., de la Cruz L., Lindsay R., Bilezikian J. P., Dempster D. W. The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 1990; 70: 930
   PubMed Web of Science ®Google Scholar
• Parisien M., Mellish R. W., Silverberg S. J., Shane E., Lindsay R., Bilezikian J. P., Dempster D. W. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 1992; 7: 913
   PubMed Web of Science ®Google Scholar
• Parisien M., Cosman F., Mellish R. W., Schnitzer M., Nieves J., Silverberg S. J., Shane E., Kimmel D., Recker R. R., Bilezikian J. P. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 1995; 10: 1393
   PubMed Web of Science ®Google Scholar
• Park C. W., Oh Y. S., Shin Y. S., Kim C. M., Kim S. Y., Choi E. J., Chang Y. S., Bang B. K. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73
   PubMed Web of Science ®Google Scholar
• Pasieka J. L., Parson L. L. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparthyroidism. World J Surg 1998; 22: 513
   PubMed Web of Science ®Google Scholar
• Patten B., Bilezikian J., Mallette L., Prince A., Engel W. K., Aurbach G. D. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med 1974; 80: 182
   PubMed Web of Science ®Google Scholar
• Peacock M. Interpretation of bone mass determinations as they relate to fractures: implications for asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991; 6: 77
   PubMedGoogle Scholar
• Petersen P. Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrinol Metab 1968; 28: 1491
   PubMed Web of Science ®Google Scholar
• Post R. M., Ballenger J. C., Goodwin F. K. Cerebrospinal fluid studies of neurotransmitter function in manic and depressive illness. Neurobiology of CSF, J. H. Wood. Plenum Press, New York 1980; 685
   Google Scholar
• Prince R. L., Schiff I., Neer R. Effects of transdermal estrogen replacement on parathyroid hormone secretion. J Clin Endocrinol Metab 1990; 71: 1284
   PubMed Web of Science ®Google Scholar
• Prince R. L. Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocr Rev 1994; 15: 301
   PubMed Web of Science ®Google Scholar
• Prince R. L., Dick I., Devine A., Price R. I., Gutteridge D. H., Kerr D., Criddle A., Garcia-Webb P., St John A. The effects of menopause and age on calcitropic hormones: A cross-sectional study of 655 healthy women aged 35–90. J Bone Miner Res 1995; 10: 835
   PubMed Web of Science ®Google Scholar
• Purnell D. C., Smith L. H., Scholz D. A., Elveback L. R., Arnaud C. D. Primary hyperparathyroidism: A prospective clinical study. Am J Med 1971; 50: 670
   PubMed Web of Science ®Google Scholar
• Rafferty M. A., Hill A. D., Zbar A. P., Shering S. G., Lucey M., McDermott E. W., O'Higgins N. J. Cervical exploration for primary hyperparathyroidism - A 25 year experience. Ir Med J 1997; 90: 188
   PubMedGoogle Scholar
• Rao D. S., Wilson R. J., Kleerekoper M., Parfitt A. M. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: Evidence for a biphasic disease course. J Clin Endocrinol Metab 1988; 67: 1294
   PubMed Web of Science ®Google Scholar
• Rastad J., Joborn C., Åkerström G., Ljunghall S. Incidence, type and severity of psychic symptoms in patients with sporadic primary hyperparathyroidism. J Endocrinol Invest 1992; 15: 149
   PubMedGoogle Scholar
• Rastad J., Åkerström G., Ljunghall S. Mortality of untreated hyperparathyroidism- A nontraditional indication for parathyroid surgery. Am J Med 1995; 99: 577
   PubMed Web of Science ®Google Scholar
• Ready A. R., Sabharawal T., Barnes A. D. Parathyroidectomy in the West Midlands. Br J Surg 1996; 83: 823
   PubMed Web of Science ®Google Scholar
• Reeve J., Meunier P. J., Parsons J. A., Bernat M., Bijvoet O. L., Courpron P., Edouard C., Lenerman L., Neez R. M., Renier J. C., Slovik D., Vismans F. J., Potts J. T., Jr. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis. Br Med J 1980; 280: 1340
   PubMed Web of Science ®Google Scholar
• Ridefelt P., Hellman P., Wallfelt C., Åkerström G., Rastad J., Gylfe E. Interaction of neomycin with Ca2+-receptor mechanism of normal and adenomatous parathyroid cells. Mol Cell Endocrinol 1992; 83: 211
   PubMed Web of Science ®Google Scholar
• Ridefelt P., Gylfe E., Åkerström G., Rastad J. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathological human parathyroid cells. Surgery 1995; 117: 56
   PubMed Web of Science ®Google Scholar
• Ridefelt P., Rastad J., Åkerström G., Hellman P., Gylfe E. Imaging of Ca(2+)-induced cytoplasmic Ca2+ responses in normal and pathological parathyroid cells. Eur J Clin Invest 1996; 26: 1166
   PubMed Web of Science ®Google Scholar
• Riggs B. L., Melton L. J., III. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899
   PubMed Web of Science ®Google Scholar
• Rizzoli R., Pache J. C., Didierjean L., Burger A., Bonjour J. P. A thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 1994; 79: 912
   PubMed Web of Science ®Google Scholar
• Robertson G. S., Johnson P. R., Bolia A., Iqbal S. J., Bell P. R. Long-term results of unilateral exploration for preoperatively localized nonfamilail parathyroid adenomas. Am J Surg 1996; 172: 311
   PubMed Web of Science ®Google Scholar
• Rodan G. A. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 1998; 38: 375
   PubMed Web of Science ®Google Scholar
• Rodrigues-Portales J. A., Fardella C. Primary hyperparathyroidism and hypertension: Persistently abnormal pressor sensitivity in normotensive patients after surgical cure. J Endocrinol Invest 1994; 17: 307
   PubMed Web of Science ®Google Scholar
• Ronni-Sivula H., Sivula A. Long-term effect of surgical treatment on the symptoms of primary hyperparathyroidism. Ann Clin Res 1985; 17: 141
   PubMedGoogle Scholar
• Rosen H. N., Lim M., Garber J., Moreau S., Bhargava H. N., Pallotta J., Spark R., Greenspan S., Rosenblatt M., Chorev M. The effect of PTH antagonist BIM-44002 on serum calcium and PTH levels in hypercalcemic hyperparathyroid patients. Calcif Tissue Int 1997; 61: 455
   PubMed Web of Science ®Google Scholar
• Rubinoff H., McCarthy N., Hiatt R. A. Hypercalcemia: Long-term follow-up with matched controls. J Chron Dis 1983; 36: 859
   PubMedGoogle Scholar
• Rudberg C., Åkerström G., Palmér M., Ljunghall S., Adami H.-O., Johansson H., Grimelius L., Thorén L., Bergström R. Late results of opertion for primary hyperparathyroidism in 441 patients. Surgery 1986; 99: 643
   PubMed Web of Science ®Google Scholar
• Rude R. K. Hyperparathyroidism. Otolaryngol Clin North Am 1996; 29: 663
   PubMed Web of Science ®Google Scholar
• Rudnicki M., Transbol I. Increasing parathyroid hormone concentrations in untreated primary hyperparathyroidism. J Int Med 1992; 232: 421
   PubMed Web of Science ®Google Scholar
• Ruijs C. D., Ottow R. T., van Vroonhoven T. J. Old age is not a contra-indication for surgery in patients with primary hyperparathyroidism. Neth J Med 1994; 45: 101
   PubMed Web of Science ®Google Scholar
• Russel C. F., Edis A. J. Surgery for primary hyperparathyroidism: Experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg 1982; 69: 244
   PubMed Web of Science ®Google Scholar
• Ryan J. A., Lee F. Effectiveness and safety of 100 consecutive parathyroidectomies. Am J Surg 1997; 173: 441
   PubMed Web of Science ®Google Scholar
• Sandström I. Om en ny körtel hos människan och åtskilliga däggdjur (On a new gland in man and several mammals). Uppsala Läkarförenings Förhandlingar 1879–1880; 15: 441
   Google Scholar
• Schiffl H., Sitter T., Lang S. M. Noradrenergic blood pressure dysregulation and cytosolic calcium in primary hyperparathyroidism. Kidney Blood Press Res 1997; 20: 290
   PubMed Web of Science ®Google Scholar
• Schluter K. D., Piper H. M. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998; 37: 34
   PubMed Web of Science ®Google Scholar
• Schmidli R. S., Wilson I., Espiner E. A., Richards A. M., Donald R. A. Aminopropylidine disphosphonate (ADP) in mild primary hyperparathyroidism: Effect on clinical status. Clin Endocrinol 1990; 32: 293
   PubMed Web of Science ®Google Scholar
• Scholz D. A., Purnell D. C. Asymptomatic primary hyperparathyroidism. Mayo Clin Proc 1981; 56: 473
   PubMed Web of Science ®Google Scholar
• Selby P. L., Peacock M. Ethinyl estradiol and norethidrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 1986; 314: 1481
   PubMed Web of Science ®Google Scholar
• Selye H. On the stimulation of new bone-formation with parathyroid extract, irradiated ergosterol. Endocrinology 1932; 16: 547
   Google Scholar
• Shane E. Medical management of asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991; 6: 131
   Google Scholar
• Sherman S. S., Hollis B. W., Tobin J. D. Vitamin D status and related parameters in a healthy population: The effects of age, sex, and season. J Endocrinol Metab 1990; 71: 405
   PubMed Web of Science ®Google Scholar
• Shoback D., Membreno L., McGhee J. High calcium and other divalent cations increase inositol triphophate in bovine parathyroid cells. Endocrinology 1988; 123: 382
   PubMed Web of Science ®Google Scholar
• Silverberg S., Shane E., de la Cruz L., Dempster D. W., Feldman F., Seldin D., Jacobs T. P., Siris E. S., Cafferty M., Parisien M. V. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989; 4: 283
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Gartenberg F., Jacobs T. P., Shane E., Siris E., Staron R. B., Bilezikian J. P. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 1995A; 80: 723
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Gartenberg F., Jacobs T. P., Shane E., Siris E., Staron R. B., McMahon D. J., Bilezikian J. P. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995B; 80: 729
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Bilezikian J. P. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 2036
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Locker F. G., Bilezikian J. P. Vertebral osteopenia: A new indicator for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 4007
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Bone H. G., 3rd, Marriott T. B., Locker F. G., Thys-Jacobs S., Dziem G., Kaatz S., Sanguinetti E. L., Bilezikian J. P. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997; 337: 1506
   PubMed Web of Science ®Google Scholar
• Silverberg S. J., Bilezikian J. P. Primary hyperparathyroidism: Still evolving?. J Bone Miner Res 1997; 12: 856
   PubMed Web of Science ®Google Scholar
• Siperstein A. E., Shen W., Chan A. K., Duh Q. Y., Clark O. H. Normocalcemic hyperparathyroidism: Biochemical and symptom profiles before and after surgery. Arch Surg 1992; 127: 1157
   PubMedGoogle Scholar
• Sivula A., Ronni-Sivula H. Natural history of treated primary hyperparathyroidism. Surg Clin North Am 1987; 67: 329
   PubMed Web of Science ®Google Scholar
• Soin A. S., Gupta S., Kochupillai N., Sharma L. K. Primary hyperparathyroidsm — An Indian Study. Indian J Cancer 1994; 31: 72
   PubMedGoogle Scholar
• Solomon B. L., Schaf M., Smallridge R. C. Psychological symptoms before and after parathyroid surgery. Am J Med 1994; 96: 101
   PubMed Web of Science ®Google Scholar
• Soreide J. A., van Heerden J. A., Grant C. S., Yau Lo C., Schleck C., Ilstrup D. M. Survival after surgical treatment for primary hyperparathyroidism. Surgery 1997; 122: 1117
   PubMed Web of Science ®Google Scholar
• Sorva A., Valvanne J., Tilvis R. S. Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med 1992; 231: 309
   PubMed Web of Science ®Google Scholar
• Sosa J. A., Powe N. R., Levine M. A., Udelsman R., Zeiger M. A. Profile of a clinical practice: Treshold for surgery and surgical outcomes for patients with primary hyperparathyroidism: A national survey of endocrine surgeons. J Clin Endocrinol Metab 1998; 83: 2658
   PubMed Web of Science ®Google Scholar
• Stefenelli T., Pacher R., Woloszczuk W., Glogar D., Kaindl F. Parathyroid hormone and calcium behavior in advanced congestive heart failure. Z Kardiol 1992; 81: 121
   PubMedGoogle Scholar
• Stefenelli T., Abela C., Frank H., Koller-Strametz J., Globits S., Bergler-Klein J., Niederle B. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab 1997A; 82: 106
   PubMed Web of Science ®Google Scholar
• Stefenelli T., Abela C., Frank H., Koller-Strametz J., Niederle B. Time course of regression of left ventricular hypertrophy after successful parathyroidectomy. Surgery 1997B; 121: 157
   PubMed Web of Science ®Google Scholar
• Stock J. L., Marcus R. Medical management of primary hyperparathyroidism. The parathyroids. Basic and clinical concepts, J. P. Bilezikian, R. Marcus, M. A. Levine. Raven Press, N.Y. 1994; 519, Ch 31
   Google Scholar
• Strewler G. J., Budayr A. A., Clark O. H., Nissenson R. A. Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient. J Clin Endocrinol Metab 1993; 76: 1373
   PubMed Web of Science ®Google Scholar
• Suda T., Shinki T., Takahashi N. The role of vitamin D in bone and intestinal cell differentation. Ann Rev Nutr 1990; 10: 195
   PubMed Web of Science ®Google Scholar
• Symons C., Fortune F., Greenbaum R. A., Dondona P. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism — an association. Br Heart J 1985; 54: 539
   PubMedGoogle Scholar
• Szabo E., Lundgren E., Juhlin C., Ljunghall S., Åkerström G., Rastad J. Double parathyroid adenoma, a clinically non-distinct entity of primary hyperparathyroidism. World J Surg 1998; 22: 708
   PubMed Web of Science ®Google Scholar
• Tal A., Graves L. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism. South Med J 1996; 89: 637
   PubMed Web of Science ®Google Scholar
• Taylor W. H., Khaleeli A. A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabet Med 1997; 14: 386
   PubMed Web of Science ®Google Scholar
• Tibblin S., Bondeson A. G., Ljungberg O. Unilateral parathyroidectomy in hyperparathyroidism due to single adenoma. Ann Surg 1982; 195: 245
   PubMed Web of Science ®Google Scholar
• Tibblin S., Pålsson N., Rydberg J. Hyperparathyroidism in the old age. Ann Chir Gyn 1983; 72: 135
   PubMedGoogle Scholar
• Tisell L. E., Jansson S., Nilsson B., Lundberg P. A., Lindstedt G. Transient rise in intact parathyroid hormone concentration after surgery for primary hyperparathyroidism. Br J Surg 1996; 83: 665
   PubMed Web of Science ®Google Scholar
• Turken S., Cafferty M., Silverberg S., de la Cruz L., Cimino C., Lange D. J., Lovelace R. E., Bilezikian J. P. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 1989; 87: 553
   PubMed Web of Science ®Google Scholar
• Turner R., Riggs B., Spelsberg T. Skeletal effects of estrogen. Endocr Rev 1994; 15: 275
   PubMed Web of Science ®Google Scholar
• Udén P., Chan A., Duh Q.-Y., Siperstein A., Clark O. H. Primary hyperparathyroidism in younger and older patients: Symptoms and out-come of surgery. World J Surg 1992; 16: 791
   PubMed Web of Science ®Google Scholar
• Urena P., Eckardt K.-U., Sarfati E., Zingraff J., Zins B., Roullet J. B., Roland E., Druecke T., Kurtz A. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: Effect of parathyroidectomy. Nephron 1991; 59: 384
   PubMed Web of Science ®Google Scholar
• Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1–34) on rat bone. Bone 1995; 16: 477
   PubMed Web of Science ®Google Scholar
• Valdemarsson S., Lindblom P., Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Intern Med 1998; 244: 241
   PubMed Web of Science ®Google Scholar
• van Heerden Jon., Grant C. S. Surgical treatment of primary hyperparathyroidism: An institutional perspective. Worl J Surg 1991; 15: 688
   PubMed Web of Science ®Google Scholar
• van Praag H. M. Neurotransmitters and CSN disease: Depression. Lancet 1982; ii: 1259
   Google Scholar
• Verges B. L., Cercueil J. P., Jacob D., Vaillant G., Brun J. M., Putelat R. Results of ultrasonically guided percutaneous ethanol injection into parathyroid adenomas in primary hyperparathyroidism. Acta Endocrinol 1993; 129: 129
   Google Scholar
• Vogel M., Hahn M., Delling G. Trabecular bone structure in patients with primary hyperparathyroidism. Virchows Arch 1995; 426: 127
   PubMed Web of Science ®Google Scholar
• Vogel L. M., Lucas R., Czako P. Unilateral parathyroid exploration. Am Surg 1998; 64: 693
   PubMed Web of Science ®Google Scholar
• von Recklinghausen F. Die Fibrose oder Deformierende Ostitis, die Osteomalacie, und die osteoplastische Carcinose, in ihren gegenseitigen Beziehungen. Festschr Rudolph Virchow zu seinem 71 Geburtstag Gewidmet, Berlin 1891
   Google Scholar
• Wallfelt C., Gylfe E., Larsson R., Ljunghall S., Rastad J., Åkerström G. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J Endocrinol 1988A; 116: 457
   PubMed Web of Science ®Google Scholar
• Wallfelt C., Lindh E., Larsson R., Johansson H., Rastad J., Åkerström G., Gylfe E. Kinetic evidence for cytoplasmatic calcium as an inhibitory messenger in parathyroid hormone release. Biochem Biophys Acta 1988B; 969: 257
   PubMedGoogle Scholar
• Wallfelt C., Gylfe E., Larsson R., Ljunghall S., Rastad J., Åkerström G. Relation between external and cytoplasmatic calcium concentrations, parathyroid hormone release and glandular weight in hyperparathyroidsm. J Endocrinol 1990A; 116: 13
   Google Scholar
• Wallfelt C., Ljunghall S., Bergström R., Rastad J., Åkerström G. Clinical characteristics and surgical treatment of sporadic primary hyperparathyroidism with emphasis on chief cell hyperplasia. Surgery 1990B; 107: 13
   PubMed Web of Science ®Google Scholar
• Wang Q., Palnitkar D. S., Parfitt A. M. The basal rate of cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism. Clin Endocrinol 1997; 46: 343
   PubMed Web of Science ®Google Scholar
• Warner J., Clifton-Bligh P., Posen S., McElduff A., Delbridge L., Reeve T. Longitudinal changes in forearm bone mineral content in primary hyperparathyroidism. J Bone Miner res 1991; 6: 91
   Google Scholar
• Weber C. J., Sewell C. W., McGarity W. C. Persistent and recurrent sporadic primary hyperparathyroidism: Histopathology, complications, and results of reoperation. Surgery 1994; 116: 991
   PubMed Web of Science ®Google Scholar
• Wells S. A. Surgical therapy of patients with primary hyperparathyroidism: Long term benefits. J Bone Miner Res 1991; 6: 143
   Google Scholar
• Welsh R., Lucas R. J., Glover J. L. Unilateral neck exploration for hyperparathyroidism based on preoperative ultrasonography. Arch surg 1990; 125: 982
   PubMedGoogle Scholar
• Wermer R. A., Khosla S., Atkinson E. J., Hodgson S. F., O'Fallon W. M., Melton L. J., III. The rise and fall of primary hyperparathyrodism: A population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 1997; 126: 433
   PubMed Web of Science ®Google Scholar
• Wermers R. A., Sundeep K., Atkinson E. J., Grant C. S., Hodgson S. F., O'Fallon M., Melton J. Survival after the diagnosis of hyperparathyroidism: A population-based study. Am J Med 1998; 104: 115
   PubMed Web of Science ®Google Scholar
• Wersäll-Robertson E., Hamberger B., Ehrén H. Increase in muscular strength following surgery for primary hyperparathyroidism. Acta Med Scand 1986; 220: 233
   PubMedGoogle Scholar
• Williams J. G., Wheeler M. H., Aston J. P., Brown R. C., Woodhead J. S. The relationship between adenoma weight and intact (1–84) parathyroid hormone level in primary hyperparathyroidism. Am J Surg 1992; 163: 301
   PubMed Web of Science ®Google Scholar
• Yoshimoto K., Yamasaki R., Sakai H., Tezuka U., Takahashi M., Iizuka M., Sekiya T., Saito Z. Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 1989; 68: 976
   PubMed Web of Science ®Google Scholar
• Zamboni W. A., Folse R. Adenoma weight: A predictor of transient hypocalcemia after parathyroidectomy. Am J Surg 1986; 152: 611
   PubMed Web of Science ®Google Scholar
• Zielke A., Hasse C., Bruns C., Sitter H., Rothmund M. Octreotide: Effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial. Surgery 1997; 121: 606
   PubMed Web of Science ®Google Scholar
• Akerström G., Bergström R., Grimelius L., Johansson H., Ljunghall S., Lundström B., Palmer M., Rastad J., Rudberg C. Relation between changes in clinical and histopathological features of primary hyperparathyroidism. World J Surg 1986A; 10: 696
   PubMed Web of Science ®Google Scholar
• Åkerström G., Rudberg C., Grimelius L., Bergström R., Johansson H., Ljunghall S., Rastad J. Histologic parathyroid abnormalities in an autopsy series. Hum Pathol 1986B; 17: 520
   PubMed Web of Science ®Google Scholar
• Åkerström G., Grimelius L. Parathyroid pathology. Current controversy in parathyroid operation and reoperation, G. Åkerström, C. Juhlin, J. Rastad. R.G. Landes Company, Austin 1994; 23
   Google Scholar
• Åkerström G., Ljunghall S., Lundgren E. Natural history of untreated primary hyperparathyroidism. Textbook of Endocrine Surgery, O. H. Clark, Q Y Duh. WB Saunders Company, Philadelphia 1997; 303
   Google Scholar
• Åsberg M., Perris C., Schalling D., Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978; 271: 5
   Google Scholar
• Asberg M., Bertilsson L., Mårtensson B., Scalia-Tomba G.-P., Thorén P., Träskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984; 69: 201
   PubMed Web of Science ®Google Scholar
• Öhrvall U., Åkerström G., Ljunghall S., Lundgren E., Juhlin C., Rastad J. Surgery for sporadic primary hyperparathyroidism in the elderly. World J Surg 1994; 18: 612
   PubMed Web of Science ®Google Scholar